Back
ESC Premium Access

Upfront triple combination therapy with ambrisentan, tadalafil and subcutaneous treprostinil in incident patients with severe pulmonary arterial hypertension

Session: New concepts in pulmonary hypertension
Topic: Treatment
Speaker: Professor M. D'Alto (Naples, IT)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Michele D'Alto

AORN Ospedali dei Colli - Monaldi Hospital, Naples (Italy)
3 presentations
3 followers

5 more presentations in this session

Validation of ESC/ERS 2015 guidelines risk score in patients with scleroderma associated pulmonary arterial hypertension (SSc-PAH)

Speaker: Doctor H. Fayed (London, GB)

Access
Abstract
Slides
Video
Thumbnail

Blood viscosity and its relevance to the diagnosis and management of pulmonary hypertension: a new elephant in the cathlab

Speaker: Doctor A. Kempny (London, GB)

Access
Abstract
Slides
Video
Thumbnail

Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities

Speaker: Professor S. Rosenkranz (Cologne, DE)

Access
Abstract
Slides
Video
Thumbnail

Waitlist outcomes for Eisenmengers patients listed for bilateral sequential lung transplant or heart-lung transplant

Speaker: Doctor K. Kearney (Sydney, AU)

Access
Abstract
Slides
Video
Thumbnail

Efficacy of pulmonary hypertension-targeted drugs for severe chronic thromboembolic pulmonary hypertension

Speaker: Doctor K. Takeuchi (Tokyo, JP)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

New concepts in pulmonary hypertension

Speakers: Professor M. D'Alto, Doctor H. Fayed, Doctor A. Kempny, Professor S. Rosenkranz, Doctor K. Kearney...
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb